Cyclosporine A in Ullrich Congenital Muscular Dystrophy: Long-Term Results

Six individuals with Ullrich congenital muscular dystrophy (UCMD) and mutations in the genes-encoding collagen VI, aging 5–9, received 3–5 mg/kg of cyclosporine A (CsA) daily for 1 to 3.2 years. The primary outcome measure was the muscle strength evaluated with a myometer and expressed as megalimbs....

Descripción completa

Detalles Bibliográficos
Autores principales: Merlini, Luciano, Sabatelli, Patrizia, Armaroli, Annarita, Gnudi, Saverio, Angelin, Alessia, Grumati, Paolo, Michelini, Maria Elena, Franchella, Andrea, Gualandi, Francesca, Bertini, Enrico, Maraldi, Nadir Mario, Ferlini, Alessandra, Bonaldo, Paolo, Bernardi, Paolo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2011
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3199070/
https://www.ncbi.nlm.nih.gov/pubmed/22028947
http://dx.doi.org/10.1155/2011/139194

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3199070/
https://www.ncbi.nlm.nih.gov/pubmed/22028947
http://dx.doi.org/10.1155/2011/139194

Ejemplares similares